Jillian R. Gunther, MD, PhD

Peer-Reviewed Articles

1. Gunther JR, Xu J, Bhutani MS, Strati P, Fang PQ, Wu SY, Dabaja BS, Dong W, Bhosale PR, Flowers CR, Nair R, Malpica Castillo L, Fayad L, Iyer SP, Parmer S, Wang M, Lee HJ, Samaniego F, Westin J, Ahmed S, Nze CC, Jain P, Neelapu SS, Rodriguez MA, Chihara D, Nastoupil LJ, Pinnix CC. Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial. Lancet Haematol 11(7):e521-e529, 2024. e-Pub 2024. PMID: 38843856.
2. Gunther JR, Pinnix CC. Measurable residual disease-driven therapy after radiotherapy for early-stage follicular lymphoma. Lancet Haematol 11(7):e472-e473, 2024. PMID: 38937019.
3. Wu SY, Damron EP, Xu J, Fang PQ, Dai J, Nair R, Malpica Castillo LE, Fayad LE, Torres-Cabala CA, Medeiros LJ, Vega F, Miranda RN, Duvic M, Pinnix CC, Dabaja BS, Iyer SP, Huen AO, Gunther JR. Radiotherapy in the treatment of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder. Int J Dermatol. e-Pub 2024. PMID: 38955474.
4. Zhang JR, Wu SY, Jain P, Ok CY, Yan F, Chen W, Oriabure O, Dabaja B, Gunther J, Fang P, Pinnix C, Wang ML, Gaulin C. Characteristics, treatment, and outcomes of mantle cell lymphoma with cutaneous involvement: a decade-long study at MD Anderson cancer center. Leuk Lymphoma:1-4. e-Pub 2024. PMID: 38972059.
5. Pinnix CC, Dabaja BS, Gunther JR, Fang PQ, Wu SY, Nastoupil LJ, Strati P, Nair R, Ahmed S, Steiner R, Westin J, Neelapu S, Rodriguez MA, Lee HJ, Wang M, Flowers C, Feng L, Esmaeli B. Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma: A Phase 2 Nonrandomized Controlled Trial. JAMA Oncol. e-Pub 2024. PMID: 38990564.
6. Fang P, Pinnix CC, Wu SY, Lee HC, Patel KK, Saini N, Becnel MR, Kaufman G, Thomas SK, Orlowski RZ, Amini B, Lin P, Dabaja BS, Gunther JR. Management and Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation Therapy. Int J Radiat Oncol Biol Phys 119(1):193-199, 2024. e-Pub 2023. PMID: 38070713.
7. Palmeri M, Bono K, Huang A, Gunther JR, Mattes MD. Characterization of Research Mentorship During Medical School for Future Radiation Oncology Trainees. Adv Radiat Oncol 9(5):101460, 2024. e-Pub 2024. PMID: 38550360.
8. Rehn S, Oertel M, Linde P, Mäurer M, Elsayad K, Pepper NB, Rolf D, Kahn JM, Plastaras JP, Gunther JR, Eich HT. Knowledge and competences in hematological malignancies amongst radiation oncology residents in Germany-results from a national survey. Strahlenther Onkol. e-Pub 2024. PMID: 38683476.
9. Wahid KA, Rooney MK, Gunther JR, Moreno AC, Pinnix CC, Thomas CR, Fuller CD. Empirically Derived Principles for Research Funding Success: A Primer for Early Career Academic Investigators. Int J Radiat Oncol Biol Phys 118(3):590-594, 2024. PMID: 38340768.
10. Bono K, Palmeri M, Huang A, Gunther JR, Mattes MD. Assessment of Medical Student Research Mentorship in Radiation Oncology. Adv Radiat Oncol 9(1):101323, 2024. e-Pub 2023. PMID: 38260215.
11. Steiner RE, Hwang SR, Khurana A, Habermann TM, Epperla N, Annunzio K, Allen PB, Baird K, Paulino D, Alderuccio JP, Lossos IS, David K, Evens AM, Pandya K, Bair SM, Kamdar M, Ba Aqeel S, Torka P, Lynch R, Smith S, Feng L, Noorani M, Ahmed S, Nair R, Vega F, Wu S, Fang P, Pinnix CC, Gunther JR, Dabaja BS, Lee HJ. Impact of Cumulative Dose of Brentuximab Vedotin on Outcomes of Frontline Therapy for Advanced Stage Hodgkin Lymphoma. Blood Adv 7(24):7485-7493, 2023. e-Pub 2023. PMID: 37603594.
12. Corrigan KL, Reeve BB, Salsman JM, Siembida EJ, Smith GL, Swartz MC, Lee KL, Afridi F, Andring LM, Bishop AJ, Gunther JR, Livingston JA, Peterson SK, Parsons SK, Roth M. Association of Patient-Reported Health-Related Quality of Life with Physician-Reported Toxicities in Adolescents and Young Adults Receiving Radiation Therapy for Cancer. JCO Oncol Pract 19(8):OP2200852, 2023. e-Pub 2023. PMID: 37311165.
13. Corrigan KL, Reeve BB, Salsman JM, Siembida EJ, Smith GL, Swartz MC, Lee KL, Afridi F, Andring LM, Bishop AJ, Gunther JR, Livingston JA, Peterson SK, Roth M. Patient-reported quality of life in adolescents and young adults with cancer who received radiation therapy. Cancer Med 12(13):14157-14170, 2023. e-Pub 2023. PMID: 37199075.
14. Corrigan KL, Reeve BB, Salsman JM, Siembida EJ, Andring LM, Geng Y, Kouzy R, Livingston JA, Peterson SK, Bishop AJ, Smith GL, Gunther JR, Parsons SK, Roth M. Health-related quality of life in adolescents and young adults with cancer who received radiation therapy: A scoping review. Support Care Cancer 31(4):230, 2023. e-Pub 2023. PMID: 36961516.
15. Kahn JM, Yang JC, Yahalom J, Dabaja BS, Vapiwala N, Hoppe BS, Tseng YD, Pinnix CC, Parikh RR, Sim AJ, Plastaras JP, Gunther JR, with the ILROG Educational Steering Committee, ARRO Executive Committee. Assessment of Lymphoma and Other Hematologic Malignancies Training Needs Among Radiation Oncology Residents: A Brief Report. J Cancer Educ 38(1):201-205, 2023. e-Pub 2021. PMID: 34601699.
16. Gunther JR, De La Cruz D, Boyce-Fappiano D, Ponnie AE, Smith L, Holliday EB, Bishop AJ, Choi SL, Koong AC, Das P, Pinnix CC. Implementation and Assessment of an Informal Virtual Elective for Medical Student Radiation Oncology Exploration During the COVID19 Pandemic: A Brief Report. J Cancer Educ 38(1):344-348, 2023. e-Pub 2022. PMID: 35013900.
17. Elmahmoud Z, Gunther JR, Christopherson K. A simple solution to create a custom scalp-sparing helmet to prevent alopecia in patients undergoing total skin electron beam therapy for cutaneous T cell lymphoma. Clin Transl Radiat Oncol 38:53-56, 2023. e-Pub 2022. PMID: 36388245.
18. Wu SY, Fang PQ, Wang EB, Ahmed S, Duvic M, Jain P, Castillo LEM, Nair R, Steiner RE, Strati P, Huen AO, Iyer SP, Pinnix CC, Dabaja BS, Gunther JR. Safety of Concurrent Radiation Therapy with Brentuximab Vedotin in the Treatment of Lymphoma. Adv Radiat Oncol 8(6):101279, 2023. e-Pub 2023. PMID: 37448588.
19. Damron EP, Qazilbash MH, Fang PQ, Wu SY, Dabaja BS, Rondon G, Hosing C, Champlin RE, Bashir Q, Shpall EJ, Knafl MK, Lee HC, Manasanch EE, Patel K, Thomas SK, Orlowski RZ, Weber DM, Pinnix CC, Gunther JR. Radiation Therapy Can Be Safely Incorporated into Pretransplantation Treatment Regimens for Patients with Multiple Myeloma. Transplant Cell Ther 29(1):37.e1-37.e7, 2023. e-Pub 2022. PMID: 37753818.
20. Gunther JR, Chadha AS, Guha S, Raju GS, Maru DM, Munsell MF, Jiang Y, Yang P, Felix E, Clemons M, Mathew GG, Singh PK, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Eng C, Delclos ME, Crane CH, Das P, Krishnan S. A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer. J Gastrointest Oncol 13(6):2938-2950, 2022. PMID: 36636059.
21. Rosenberg DM, Braunstein SE, Fields EC, Gillespie EF, Gunther JR, Jimenez RB, Yechieli RL, Golden DW. Radiation Oncology Education Collaborative Study Group Annual Spring Symposium: Initial Impact and Feedback. J Cancer Educ 37(5):1504-1509, 2022. e-Pub 2021. PMID: 33728871.
22. Hinchcliff E, Gunther J, Ponnie AE, Bednarski B, Onstad M, Shafer A, Frumovitz M, Jazaeri A, Urbauer D, Bodurka DC. A Not So Perfect Score: Factors Associated with the Rate of Straight Line Scoring in Oncology Training Programs. J Cancer Educ 37(3):615-620, 2022. e-Pub 2020. PMID: 32839894.
23. Marques-Piubelli ML, Parra ER, Feng L, Soto LS, Gallardo M, Gouni S, Samaniego F, Noorani M, Hagemeister FB, Westin JR, Lee HJ, Rodriguez MA, Neelapu SS, Gunther JR, Fowler NH, Flowers CR, Wistuba II, Nastoupil LJ, Vega F, Strati P. SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab. Blood Adv 6(11):3286-3293, 2022. e-Pub 2022. PMID: 35359004.
24. Nieto Y, Gruschkus S, Valdez BC, Jones RB, Anderlini P, Hosing C, Popat U, Qazilbash M, Kebriaei P, Alousi A, Saini N, Srour S, Rezvani K, Ramdial J, Barnett M, Gulbis A, Shigle TL, Ahmed S, Iyer S, Lee H, Nair R, Parmar S, Steiner R, Dabaja B, Pinnix C, Gunther J, Cuglievan B, Mahadeo K, Khazal S, Chuang H, Champlin R, Shpall EJ, Andersson BS. Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis. Haematologica 107(4):899-908, 2022. e-Pub 2022. PMID: 33951890.
25. Huang A, Gunther JR, Lin LL. Analyzing the Role of Research in the Radiation Oncology Match. Adv Radiat Oncol 7(3):100891, 2022. e-Pub 2022. PMID: 35243182.
26. Huang A, Gunther JR, Lin LL. In Reply to Sindhu et al. Adv Radiat Oncol 7(6):101067, 2022. e-Pub 2022. PMID: 36420206.
27. Al Feghali KA, Fang P, Gule-Monroe M, Milgrom S, Khoury JD, Gunther JR, Sheu T, Nair R, Ahmed S, Steiner R, Strati P, Shpall EJ, Nieto YL, Hosing C, Nastoupil LJ, Westin JR, Neelapu SS, Fowler N, Flowers C, Pinnix CC, Dabaja BS. Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapy. Leuk Lymphoma 62(10):1-8, 2021. e-Pub 2021. PMID: 33942701.
28. Dayde D, Gunther J, Hirayama Y, Weksberg DC, Boutin A, Parhy G, Aguilar-Bonavides C, Wang H, Katayama H, Abe Y, Do KA, Hara K, Kinoshita T, Komori K, Shimizu Y, Tajika M, Niwa Y, Wang YA, DePinho R, Hanash S, Krishnan S, Taguchi A. Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal Cancer. Cancers (Basel) 13(14), 2021. e-Pub 2021. PMID: 34298853.
29. Nelson BA, Lapen K, Schultz O, Nangachiveettil J, Braunstein SE, Fernandez C, Fields EC, Gunther JR, Jeans E, Jimenez RB, Kharofa JR, Laucis A, Yechieli RL, Gillespie EF, Golden DW. The Radiation Oncology Education Collaborative Study Group 2020 Spring Symposium: Is Virtual the New Reality?. Int J Radiat Oncol Biol Phys 110(2):315-321, 2021. e-Pub 2020. PMID: 33373657.
30. Augustyn A, Medeiros LJ, Ludmir EB, Gunther J, Fang P, Li S, Ok CY, Bankston ME, Verma V, Pasalic D, Ahmed S, Nastoupil LJ, Westin JR, Strati P, Neelapu SS, Nair R, Steiner RE, Iyer SP, Rodriguez A, Fayad LE, Flowers CR, Dabaja BS, Pinnix CC. The impact of cell-of-origin, MYC/Bcl-2 dual expression and MYC rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy. Leuk Lymphoma 62(6):1-12, 2021. e-Pub 2021. PMID: 33480830.
31. Fang P, Gunther JR, Pinnix CC, Dong W, Strati P, Nastoupil LJ, Steiner RE, Ahmed S, Damron EP, Fowler N, Nair R, Westin JR, Neelapu S, Ha CS, Dabaja BS. A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma. Int J Radiat Oncol Biol Phys 109(5):1414-1420, 2021. e-Pub 2020. PMID: 33309978.
32. Strati P, Cheng PTM, Steiner RE, Alcedo Andrade PE, Feng L, Sano D, Rao VA, Singh P, Miranda R, Gunther JR, Pinnix CC, Dabaja BS, Cuglievan B, Xing K, Villa D, Skinnider B, Sehn LH, Connors JM, Nieto Y, Ahmed S, Lee HJ, Savage KJ. Outcome of relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: a North American analysis. Br J Haematol 192(3):560-567, 2021. PMID: 33517581.
33. Fang PQ, Gunther JR, Wu SY, Dabaja BS, Nastoupil LJ, Ahmed S, Neelapu SS, Pinnix CC. Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy. Front Oncol 11:648655, 2021. e-Pub 2021. PMID: 33842363.
34. Zhu LL, Martin RM, Gunther JR, Wong PF, Hancock D, Moreno AC, Dabaja BS, Pinnix CC. Daily computed tomography image guidance: dosimetric advantages outweigh low-dose radiation exposure for treatment of mediastinal lymphoma. Radiother Oncol 152:14-18, 2020. e-Pub 2020. PMID: 32593645.
35. Dabaja BS, Ng AK, Terezakis SA, Plastaras JP, Yunes M, Wilson LD, Yang J, Gunther JR, Specht L, Yahalom J. ILROG Lymphoma Mini-Atlas Part II, Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys 108(4):977-978, 2020. e-Pub 2020. PMID: 32768256.
36. Christopherson KM, Gunther JR, Fang P, Peterson SL, Roach KE, Wong PF, Mirkovic D, Lim TY, Wang H, Wang XA, Wang C, Garcia J, Dabaja BS, Pinnix CC. Decreased heart dose with deep inspiration breath hold for the treatment of gastric lymphoma with IMRT. Clin Transl Radiat Oncol 24:79-82, 2020. e-Pub 2020. PMID: 32642563.
37. Pinnix CC, Gunther JR, Fang P, Bankston ME, Milgrom SA, Boyce D, Lee HJ, Nair R, Steiner R, Strati P, Ahmed S, Iyer SP, Westin J, Parmar S, Rodriguez MA, Nastoupil L, Neelapu S, Flowers C, Dabaja BS. Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy. JAMA Netw Open 3(9):e2013935, 2020. e-Pub 2020. PMID: 32990738.
38. Glober G, Gunther J, Fang P, Milgrom S, Korivi BR, Jensen CT, Wagner-Bartak NA, Ahmed S, Lee HJ, Nair R, Steiner R, Parmar S, Iyer S, Westin J, Fayad L, Rodriguez MA, Neelapu S, Nastoupil L, Flowers CR, Dabaja BS, Pinnix CC. Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET-CT-documented First Remission. Clin Lymphoma Myeloma Leuk 20(8):533-541, 2020. e-Pub 2020. PMID: 32291233.
39. Elhammali A, Amini B, Ludmir EB, Gunther JR, Milgrom SA, Pinnix CC, Andraos T, Yoder A, Weber D, Orlowski R, Manasanch E, Patel K, Strati P, Nair R, Lee HC, Thomas S, Iyer S, Kaufmann G, Garg N, Dabaja BS. New Paradigm for Radiation in Multiple Myeloma: Lower yet effective dose to avoid radiation toxicity. Haematologica 105(7):e355-e357, 2020. e-Pub 2020. PMID: 31919088.
40. Jimenez RB, Johnson A, Padilla L, Yechieli R, Forman R, Horick N, Thomas H, Gunther JR, Olivier K, Golden DW, Fields E, Radiation Oncology Education Collaborative Study Group. The Impact of an Introductory Radiation Oncology Curriculum (IROC) for Radiation Oncology Trainees Across the United States and Canada. Int J Radiat Oncol Biol Phys 107(3):408-416, 2020. e-Pub 2020. PMID: 32057993.
41. Toomey S, Gunther J, Carr A, Weksberg DC, Thomas V, Salvucci M, Bacon O, Sherif EM, Fay J, Kay EW, Sheehan KM, McNamara DA, Sanders KL, Mathew G, Breathnach OS, Grogan L, Morris PG, Foo WC, You YN, Prehn JH, O'Neill B, Krishnan S, Hennessy BT, Furney SJ. Genomic and Transcriptomic Characterisation of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Cancers (Basel) 12(7), 2020. e-Pub 2020. PMID: 32640573.
42. Pinnix CC, Gunther JR, Dabaja BS, Strati P, Fang P, Hawkins MC, Adkins S, Westin J, Ahmed S, Fayad L, Lee HJ, Nair R, Steiner RE, Iyer SP, Rodriguez MA, Wang M, Flowers C, Neelapu SS, Nastoupil LJ. Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma. Blood Adv 4(13):2871-2883, 2020. PMID: 32589728.
43. Gunther JR, Pinnix CC, Glober GR, Christopherson KM, Fang P, Lee HJ, Ahmed S, Steiner RE, Nair R, Strati P, Neelapu SS, Nastoupil LJ, Dabaja BS. Partial omission of bleomycin for early-stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?. EJHaem 1(1):272-276, 2020. e-Pub 2020. PMID: 32864660.
44. Gunther JR. Involved-Site Radiation Therapy if Minimal Toxicity. Int J Radiat Oncol Biol Phys 107(1):20-21, 2020. PMID: 32277916.
45. Gunther JR, Park C, Dabaja BS, Milgrom SA, Cruz Chamorro RJ, Medeiros LJ, Khoury JD, Garg N, Amini B, Steiner R, Nair R, Strati P, Westin JR, Lee HJ, Fowler N, Nastoupil L, Neelapu SS, Pinnix CC. Radiation therapy for salivary gland MALT lymphoma: Ultra-low dose treatment achieves encouraging early outcomes and spares salivary function. Leuk Lymphoma 61(1):1-5, 2020. e-Pub 2019. PMID: 31373240.
46. Sunderland AJ, Steiner RE, Al Zahrani M, Pinnix CC, Dabaja BS, Gunther JR, Nastoupil LJ, Jerkeman M, Joske D, Cull G, El-Galaly T, Villa D, Cheah CY. An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement. Cancer Med 9(2):663-670, 2020. e-Pub 2019. PMID: 31808316.
47. Moreno AC, Gunther JR, Milgrom S, Fuller CD, Williamson T, Liu A, Wu R, Zhu XR, Dabaja BS, Pinnix CC. Effect of Deep Inspiration Breath Hold on Normal Tissue Sparing with Intensity Modulated Radiation Therapy Versus Proton Therapy for Mediastinal Lymphoma. Adv Radiat Oncol 5(6):1255-1266, 2020. e-Pub 2020. PMID: 33305086.
48. Andraos TY, Ayoub Z, Nastoupil LJ, Milgrom SA, Pinnix CC, Ng SP, Gunther JR, Fowler NH, Neelapu SS, Samaniego F, Fayad LE, Dabaja BS. Additional therapy improves outcomes in completely resected, limited-stage follicular lymphoma. Leuk Lymphoma 60(13):1-8, 2019. e-Pub 2019. PMID: 31234671.
49. Ayoub Z, Andraos T, Milgrom SA, Pinnix CC, Dabaja BS, Ng SP, Gunther JR, Khoury JD, Fowler NH, Neelapu SS, Samaniego F, Fayad LE, Nastoupil LJ. Limited stage grade 3 follicular lymphoma patients can experience favorable outcomes with combined modality therapy. Leuk Lymphoma 60(10):1-9, 2019. e-Pub 2019. PMID: 30942648.
50. Milgrom SA, Varghese B, Gladish GW, Choi AD, Dong W, Patel ZS, Chung CC, Rao A, Pinnix CC, Gunther JR, Dabaja BS, Lin SH, Hoffman KE, Huff JL, Slagowski J, Abe JI, Iliescu CA, Banchs J, Yusuf SW, Lopez-Mattei JC. Coronary Artery Dose-Volume Parameters Predict Risk of Calcification After Radiation Therapy. J Cardiovasc Imaging 27(4):268-279, 2019. PMID: 31614398.
51. Elhammali A, Milgrom SA, Amini B, Gunther JR, Yoder A, Ludmir EB, Moon B, Weber DM, Thomas SK, Garg N, Manasanch EE, Patel KK, Orlowski RZ, Lee HC, Bird JE, Satcher R, Lin P, Pinnix CC, Dabaja BS. Postoperative Radiotherapy for Multiple Myeloma of Long Bones: Should the Entire Rod Be Treated?. Clin Lymphoma Myeloma Leuk 19(8):e465, 2019. e-Pub 2019. PMID: 31133526.
52. Ning MS, Pinnix CC, Chapman BV, Gunther JR, Milgrom SA, Khoury JD, Jain P, Chen WY, Oriabure ON, Badillo MR, Wang LM, Dabaja BS. Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma. Blood Adv 3(13):2035-2039, 2019. PMID: 31289030.
53. Pinnix CC, Gunther JR, Milgrom SA, Cruz Chamorro RJ, Medeiros LJ, Khoury JD, Amini B, Neelapu S, Lee HJ, Westin J, Fowler N, Nastoupil L, Dabaja B. Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa- Associated Lymphoid Tissue (MALT) Lymphoma. Int J Radiat Oncol Biol Phys 104(2):447-455, 2019. e-Pub 2019. PMID: 30769175.
54. Strati P, Lee ST, Teegavarupu P, Karri A, Anireddy S, Hagemeister FB, Romaguera J, Fayad LE, Rodriguez MA, Samaniego F, Fowler N, Westin J, Wang M, Lee HJ, Pinnix C, Gunther JR, Dabaja B, Feng L, Davis RE, Neelapu SS. Frontline antibiotic therapy for early-stage Helicobacter pylori-negative gastric MALT lymphoma. Am J Hematol 94(6):E150-E153, 2019. e-Pub 2019. PMID: 30785215.
55. Andraos T, Ayoub Z, Nastoupil L, Pinnix C, Milgrom S, Gunther J, Ng SP, Fowler N, Neelapu S, Samaniego F, Dabaja B. Early Stage Extranodal Follicular Lymphoma: Characteristics, Management, and Outcomes. Clin Lymphoma, Myeloma & Leuk 19(6):381-389, 2019.
56. Yoder AK, Gunther JR, Milgrom SA, Pham M, Hancock D, McSpadden K, Garcia J, Mirkovic D, Dabaja BS, Pinnix CC. Rainbow IMRT and Volumetric Imaging for Anterior Mesenteric Targets. Pract Radiat Oncol 9(3):147-152, 2019. e-Pub 2019. PMID: 30708131.
57. Rooney MK, Gunther JR, Gillespie EF, Golden DW. In Regard to Marcrom et al. Int J Radiat Oncol Biol Phys 104(1):220-221, 2019. PMID: 30967228.
58. Pinnix CC, Milgrom SA, Cheah CY, Gunther JR, Ludmir EB, Wogan CF, Nastoupil LJ, Neelapu SS, Westin J, Lee HJ, Iyer SP, Steiner RE, Fayad LE, Fowler NH, Wang ML, Samaniego F, Rodriguez MA, Rich AE, Medeiros LJ, Dabaja BS. Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma. Blood Adv 3(9):1356-1367, 2019. PMID: 31036721.
59. Ludmir EB, Milgrom SA, Pinnix CC, Gunther JR, Westin J, Fayad LE, Khoury JD, Medeiros LJ, Dabaja BS, Nastoupil LJ. Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue. Clin Lymphoma Myeloma Leuk 19(4):244-250, 2019. e-Pub 2019. PMID: 30686775.
60. Chadha AS, Gunther JR, Hsieh CE, Aliru M, Mahadevan LS, Venkatesulu BP, Crane CH, Das P, Herman JM, Koay EJ, Taniguchi C, Holliday EB, Minsky BD, Suh Y, Park P, Sawakuchi G, Beddar S, Odisio BC, Gupta S, Loyer E, Kaur H, Raghav K, Javle MM, Kaseb AO, Krishnan S. Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma. Radiother Oncol 133:54-61, 2019. e-Pub 2019. PMID: 30935582.
61. Milgrom SA, Elhalawani H, Lee J, Wang Q, Mohamed ASR, Dabaja BS, Pinnix CC, Gunther JR, Court L, Rao A, Fuller CD, Akhtari M, Aristophanous M, Mawlawi O, Chuang HH, Sulman EP, Lee HJ, Hagemeister FB, Oki Y, Fanale M, Smith GL. A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma. Sci Rep 9(1):1322, 2019. e-Pub 2019. PMID: 30718585.
62. Milgrom SA, Pinnix CC, Gunther JR, Fanale M, Dabaja BS. Post-ABVD biopsy results, and not post-ABVD FDG-PET results, predict outcome in early-stage Hodgkin lymphoma: response to Adams and Kwee. Br J Haematol 184(2):292-293, 2019. e-Pub 2017. PMID: 29265334.
63. Yoder AK, Gunther JR, Milgrom SA, Mirkovic D, Nastoupil L, Neelapu S, Fanale M, Fowler N, Westin J, Lee HJ, Rodriguez MA, Iyer SP, Fayad L, Nieto YL, Hosing C, Ahmed S, Medeiros LJ, Khoury JD, Garg N, Amini B, Dabaja BS, Pinnix CC. Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery with Volumetric Image-guided Intensity Modulated Radiation Therapy. Clin Lymphoma Myeloma Leuk 19(1):e51-e61, 2019. e-Pub 2018. PMID: 30360985.
64. Ludmir EB, Milgrom SA, Pinnix CC, Gunther JR, Westin J, Oki Y, Fayad LE, Medeiros LJ, Dabaja BS, Nastoupil LJ. Primary breast diffuse large B-cell lymphoma: Treatment strategies and patterns of failure. Leuk Lymphoma 59(12):1-8, 2018. e-Pub 2018. PMID: 29697005.
65. Pinnix CC, Wirth A, Milgrom SA, Andraos TY, Aristophanous M, Pham M, Hancock D, Ludmir EB, Gunther JR, Fanale MA, Oki Y, Nastoupil L, Chuang HH, Mikhaeel NG, Dabaja BS. Omitting cardiophrenic lymph nodes in the treatment of patients with Hodgkin lymphoma via modified involved-site radiation therapy. Leuk Lymphoma 59(11):1-10, 2018. e-Pub 2018. PMID: 29616834.
66. Rooney MK, Zhu F, Gillespie EF, Gunther JR, McKillip RP, Lineberry M, Tekian A, Golden DW. Simulation as More Than a Treatment-Planning Tool: A Systematic Review of the Literature on Radiation Oncology Simulation-Based Medical Education. Int J Radiat Oncol Biol Phys 102(2):257-283, 2018. e-Pub 2018. PMID: 30191859.
67. Gunther JR, Jimenez RB, Yechieli RL, Parekh A, Berman AT, Braunstein SE, Hirsch AE, Gillespie EF, Vapiwala N, Thomas CR, Fields EC, Golden DW. Introductory Radiation Oncology Curriculum: Report of a National Needs Assessment and Multi-institutional Pilot Implementation. Int J Radiat Oncol Biol Phys 101(5):1029-1038, 2018. e-Pub 2018. PMID: 29859794.
68. Pinnix CC, Cella L, Andraos TY, Ayoub Z, Milgrom SA, Gunther J, Thosani S, Wogan C, Conson M, D'Avino V, Oki Y, Fanale M, Lee HJ, Neelapu S, Fayad L, Hagemeister F, Rodriguez MA, Nastoupil LJ, Nieto Y, Qiao W, Pacelli R, Dabaja B. Predictors of hypothyroidism in Hodgkin lymphoma survivors after intensity-modulated versus 3-dimensional radiation therapy. Int J Radiat Oncol Biol Phys 101(3):530-540, 2018. e-Pub 2018. PMID: 29681481.
69. Pinnix CC, Ng AK, Dabaja BS, Milgrom SA, Gunther JR, Fuller CD, Smith GL, Abou Yehia Z, Qiao W, Wogan CF, Akhtari M, Mawlawi O, Medeiros LJ, Chuang HH, Martin-Doyle W, Armand P, LaCasce AS, Oki Y, Fanale M, Westin J, Neelapu S, Nastoupil L. Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL. Blood Adv 2(11):1334-1343, 2018. PMID: 29895624.
70. Milgrom SA, Pinnix CC, Chi TL, Vu TH, Gunther JR, Sheu T, Fowler N, Westin JR, Nastoupil LJ, Oki Y, Fayad LE, Neelapu S, Rodriguez MA, Hagemeister FB, Fanale MA, Lee HJ, Hosing C, Ahmed S, Nieto Y, Shpall EJ, Dabaja BS. Radiation Therapy as an Effective Salvage Strategy for Secondary CNS Lymphoma. Int J Radiat Oncol Biol Phys 100(5):1146-1154, 2018. e-Pub 2018. PMID: 29452771.
71. Stecklein SR, Frumovitz M, Klopp AH, Gunther JR, Eifel PJ. Effectiveness of definitive radiotherapy for squamous cell carcinoma of the vulva with gross inguinal lymphadenopathy. Gynecol Oncol 148(3):474-479, 2018. e-Pub 2018. PMID: 29336837.
72. Reddy JP, Hernandez M, Gunther JR, Dabaja BS, Martin GV, Jiang W, Akhtari M, Allen PK, Atkinson BJ, Smith GL, Pinnix CC, Milgrom SA, Abou Yehia Z, Osborne EM, Oki Y, Lee H, Hagemeister F, Fanale MA. Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical hodgkin lymphoma. Br J Haematol 180(4):545-549, 2018. e-Pub 2017. PMID: 29271057.
73. Akhtari M, Milgrom SA, Pinnix CC, Reddy JP, Dong W, Smith GL, Mawlawi O, Abou Yehia Z, Gunther J, Osborne EM, Andraos TY, Wogan CF, Rohren E, Garg N, Chuang H, Khoury JD, Oki Y, Fanale M, Dabaja BS. Re-classifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation. Blood 131(1):84-94, 2018. e-Pub 2017. PMID: 29038339.
74. Ludmir EB, Gutschenritter T, Pinnix CC, Gunther JR, Nastoupil LJ, Khoury JD, Medeiros LJ, Dabaja BS, Milgrom SA. Coincident primary breast lymphoma and gastrointestinal stromal tumor: Case series and molecular mechanisms. Onco Targets Ther 11:8937-8942, 2018. e-Pub 2018. PMID: 30573980.
75. Sheu T, Milgrom SA, Andraos TY, Gunther JR, Chi L, Nastoupil L, Fowler N, Oki Y, Fanale MA, Fayad LE, Hagemeister F, Neelapu SS, Medeiros LJ, Hosing C, Nieto Y, Ahmed S, Alousi AM, Dabaja B, Pinnix CC. Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy. Adv Radiat Oncol 3(4):639-646, 2018. e-Pub 2018. PMID: 30370365.
76. Jensen GL, Dabaja BS, Pinnix CC, Gunther JR, Huen A, Duvic M, Oki Y, Fanale M, Hosing C, Milgrom SA. Radiotherapy in Patients with Mycosis Fungoides and Central Nervous System Involvement. Case Rep Oncol 11(3):721-728, 2018. e-Pub 2018. PMID: 30519174.
77. Milgrom SA, Pinnix CC, Chuang H, Oki Y, Akhtari M, Mawlawi O, Garg N, Gunther JR, Reddy JP, Smith GL, Rohren E, Hagemeister FB, Lee HJ, Fayad LE, Dong W, Osborne EM, Abou Yehia Z, Fanale M, Dabaja BS. Early-stage Hodgkin lymphoma outcomes after combined modality therapy according to the post-chemotherapy 5-point score: can residual pet-positive disease be cured with radiotherapy alone?. Br J Haematol 179(3):488-496, 2017. e-Pub 2017. PMID: 28832956.
78. Gunther JR, Rahman AR, Dong W, Dabaja BS, Yehia ZA, Kebriaei P, Rondon G, Pinnix CC, Milgrom SA, Allen PK, Smith GL. Proton vs. photon craniospinal irradiation for hematologic malignancies involving the CNS: Effectiveness and toxicity in the setting of stem cell transplant. Practical Radiation Oncology 7(6):e401-e408, 2017.
79. Gunther JR, Christensen EN, Allen PK, Ramondetta LM, Jhingran A, Fleming ND, Euscher ED, Lu KH, Eifel PJ, Klopp AH. Role of Radiation Therapy in the Multidisciplinary Management of Uterine Carcinosarcoma. Int J Gynecol Cancer. e-Pub 2017. PMID: 28930812.
80. Gillespie EF, Panjwani N, Golden DW, Gunther J, Chapman TR, Brower JV, Kosztyla R, Larson G, Neppala P, Moiseenko V, Bykowski J, Sanghvi P, Murphy JD. Multi-institutional Randomized Trial Testing the Utility of an Interactive Three-dimensional Contouring Atlas Among Radiation Oncology Residents. Int J Radiat Oncol Biol Phys 98(3):547-554, 2017. e-Pub 2016. PMID: 28262474.
81. Sato M, Gunther JR, Mahajan A, Jo E, Paulino AC, Adesina AM, Jones JY, Ketonen LM, Su JM, Okcu MF, Khatua S, Dauser RC, Whitehead WE, Weinberg J, Chintagumpala MM. Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapy. Cancer 123(13):2570-2578, 2017. e-Pub 2017. PMID: 28267208.
82. Milgrom SA, Dong W, Akhtari M, Smith GL, Pinnix CC, Mawlawi O, Rohren E, Garg N, Chuang H, Yehia ZA, Reddy JP, Gunther JR, Khoury JD, Suki T, Osborne EM, Oki Y, Fanale M, Dabaja BS. Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville Score. Int J Radiat Oncol Biol Phys 97(2):333-338, 2017. e-Pub 2016. PMID: 28068241.
83. Gunther JR, Rahman AR, Dong W, Yehia ZA, Kebriaei P, Rondon G, Pinnix CC, Milgrom SA, Allen PK, Dabaja BS, Smith GL. Craniospinal irradiation prior to stem cell transplant for hematologic malignancies with CNS involvement: Effectiveness and toxicity after photon or proton treatment. Pract Radiat Oncol 7(6):e401-e408, 2017. e-Pub 2017. PMID: 28666906.
84. Gunther JR, Chadha AS, Kattepogu KV, Grant JD, Weksberg D,Park IJ, Eng C, Kopetz S, Das P, Delclos ME, Kaur H, Maru DM, Skibber JM, Rodriguez-Bigas MA, You YN, Krishnan S, Chang GJ. Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging and long-term outcomes without increased toxicity: A matched-pair analysis. Advances in Radiation Oncology 2(3):455-464, 2017.
85. Gunther JR, Chadha AS, Shin US, Park IJ, Kattepogu KV, Grant JD, Weksberg DC, Eng C, Kopetz SE, Das P, Delclos ME, Kaur H, Maru DM, Skibber JM, Rodriguez-Bigas MA, You YN, Krishnan S, Chang GJ. Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: A matched-pair analysis. Adv Radiat Oncol 2(3):455-464, 2017. e-Pub 2017. PMID: 29114614.
86. Abou Yehia Z, Mikhaeel GN, Smith G, Pinnix CC, Milgrom SA, Tang C, Jiang W, Fanale MA, Oki Y, Shank JH, Horace T, Reddy J, Akhtari M, Gunther JR, Suki T, Allen PK, Turner S, Mawlawi O, Dabaja BS. Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?. Int J Radiat Oncol Biol Phys 96(5):951-958, 2016. e-Pub 2016. PMID: 27742539.
87. Peeler CR, Mirkovic D, Titt U, Blanchard P, Gunther JR, Mahajan A, Mohan R, Grosshans DR. Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma. Radiother Oncol 121(3):395-401, 2016. e-Pub 2016. PMID: 27863964.
88. Ohtsuka M, Ling H, Ivan C, Pichler M, Matsushita D, Goblirsch M, Stiegelbauer V, Shigeyasu K, Zhang X, Chen M, Vidhu F, Bartholomeusz GA, Toiyama Y, Kusunoki M, Doki Y, Mori M, Song S, Gunther JR, Krishnan S, Slaby O, Goel A, Ajani JA, Radovich M, Calin GA. H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer. EBioMedicine 13:113-124, 2016. e-Pub 2016. PMID: 27789274.
89. Chadha AS, Khoo A, Aliru ML, Arora HK, Gunther JR, Krishnan S. Recent Advances and Prospects for Multimodality Therapy in Pancreatic Cancer. Semin Radiat Oncol 26(4):320-37, 2016. e-Pub 2016. PMID: 27619253.
90. Gunther JR, Fanale MA, Reddy JP, Akhtari M, Smith GL, Pinnix CC, Milgrom SA, Yehia ZA, Allen PK, Osborne EM, Mawlawi O, Dabaja BS. Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy with Radiation. Int J Radiat Oncol Biol Phys 96(1):110-8, 2016. e-Pub 2016. PMID: 27325479.
91. Gunther JR, Liauw SL, Choi S, Mohamed AS, Thaker NG, Fuller CD, Stepaniak CJ, Das P, Golden DW. A Prostate Fossa Contouring Instructional Module: Implementation and Evaluation. J Am Coll Radiol 13(7):835-841.e1, 2016. e-Pub 2016. PMID: 27210232.
92. Akhtari M, Reddy JP, Pinnix CC, Allen PK, Osborne EM, Gunther JR, Milgrom SA, Smith GL, Wogan CF, Fowler N, Rodriguez MA, Dabaja B. Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy. Leuk Lymphoma 57(1):34-8, 2016. e-Pub 2015. PMID: 25860237.
93. Chadha AS, Skinner HD, Gunther JR, Munsell MF, Das P, Minsky BD, Delclos ME, Chatterjee D, Wang H, Clemons M, George G, Singh PK, Katz MH, Fleming JB, Javle MM, Wolff RA, Varadhachary GR, Crane CH, Krishnan S. Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer. PLoS One 11(6):e0156910, 2016. e-Pub 2016. PMID: 27336466.
94. Gunther J, Krishnan S. The evolving evidence for the efficacy and safety of charged particle therapy for hepatocellular carcinoma - A commentary. Ann Transl Med 3(22):364, 2015. PMID: 26807419.
95. Reddy JP, Akhtari M, Smith GL, Pinnix C, Osborne EM, Gunther JR, Allen PK, Yehia ZA, Fanale M, Rodriguez MA, Fowler N, Milgrom SA, Wogan CF, Dabaja BS. Outcomes After Chemotherapy Followed by Radiation for Stage IIB Hodgkin Lymphoma with Bulky Disease. Clin Lymphoma Myeloma Leuk 15(11):664-670.e2, 2015. e-Pub 2015. PMID: 26321471.
96. Gunther JR, Sato M, Chintagumpala M, Ketonen L, Jones JY, Allen PK, Paulino AC, Okcu MF, Su JM, Weinberg J, Boehling NS, Khatua S, Adesina A, Dauser R, Whitehead WE, Mahajan A. Imaging Changes in Pediatric Intracranial Ependymoma Patients Treated with Proton Beam Radiation Therapy Compared to Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys 93(1):54-63, 2015. e-Pub 2015. PMID: 26279024.
97. Moore TW, Gunther JR, Katzenellenbogen JA. Estrogen receptor alpha/co-activator interaction assay: TR-FRET. Methods Mol Biol 1278:545-53, 2015. PMID: 25859975.
98. Bertini S, De Cupertinis A, Granchi C, Bargagli B, Tuccinardi T, Martinelli A, Macchia M, Gunther JR, Carlson KE, Katzenellenbogen JA, Minutolo F. Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximes. Eur J Med Chem 46(6):2453-62, 2011. e-Pub 2011. PMID: 21481497.
99. Sun A, Moore TW, Gunther JR, Kim MS, Rhoden E, Du Y, Fu H, Snyder JP, Katzenellenbogen JA. Discovering small-molecule estrogen receptor α/coactivator binding inhibitors: high-throughput screening, ligand development, and models for enhanced potency. ChemMedChem 6(4):654-66, 2011. e-Pub 2011. PMID: 21365764.
100. Jeyakumar M, Carlson KE, Gunther JR, Katzenellenbogen JA. Exploration of dimensions of estrogen potency: parsing ligand binding and coactivator binding affinities. J Biol Chem 286(15):12971-82, 2011. e-Pub 2011. PMID: 21321128.
101. Moore TW, Gunther JR, Katzenellenbogen JA. Probing the topological tolerance of multimeric protein interactions: evaluation of an estrogen/synthetic ligand for FK506 binding protein conjugate. Bioconjug Chem 21(10):1880-9, 2010. PMID: 20919698.
102. Kim SH, Gunther JR, Katzenellenbogen JA. Monitoring a coordinated exchange process in a four-component biological interaction system: development of a time-resolved terbium-based one-donor/three-acceptor multicolor FRET system. J Am Chem Soc 132(13):4685-92, 2010. PMID: 20230029.
103. Williams AB, Weiser PT, Hanson RN, Gunther JR, Katzenellenbogen JA. Synthesis of biphenyl proteomimetics as estrogen receptor-alpha coactivator binding inhibitors. Org Lett 11(23):5370-3, 2009. PMID: 19902964.
104. Gunther JR, Parent AA, Katzenellenbogen JA. Alternative inhibition of androgen receptor signaling: peptidomimetic pyrimidines as direct androgen receptor/coactivator disruptors. ACS Chem Biol 4(6):435-40, 2009. PMID: 19441848.
105. Gunther JR, Du Y, Rhoden E, Lewis I, Revennaugh B, Moore TW, Kim SH, Dingledine R, Fu H, Katzenellenbogen JA. A set of time-resolved fluorescence resonance energy transfer assays for the discovery of inhibitors of estrogen receptor-coactivator binding. J Biomol Screen 14(2):181-93, 2009. e-Pub 2009. PMID: 19196699.
106. Minutolo F, Bertini S, Granchi C, Marchitiello T, Prota G, Rapposelli S, Tuccinardi T, Martinelli A, Gunther JR, Carlson KE, Katzenellenbogen JA, Macchia M. Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta. J Med Chem 52(3):858-67, 2009. PMID: 19128016.
107. LaFrate AL, Gunther JR, Carlson KE, Katzenellenbogen JA. Synthesis and biological evaluation of guanylhydrazone coactivator binding inhibitors for the estrogen receptor. Bioorg Med Chem 16(23):10075-84, 2008. e-Pub 2008. PMID: 18976929.
108. Kim SH, Gunther JR, Katzenellenbogen JA. Nonclassical SNAPFL analogue as a Cy5 resonance energy transfer partner. Org Lett 10(21):4931-4, 2008. e-Pub 2008. PMID: 18841988.
109. Parent AA, Gunther JR, Katzenellenbogen JA. Blocking estrogen signaling after the hormone: pyrimidine-core inhibitors of estrogen receptor-coactivator binding. J Med Chem 51(20):6512-30, 2008. e-Pub 2008. PMID: 18785725.
110. Gunther JR, Moore TW, Collins ML, Katzenellenbogen JA. Amphipathic benzenes are designed inhibitors of the estrogen receptor alpha/steroid receptor coactivator interaction. ACS Chem Biol 3(5):282-6, 2008. PMID: 18484708.
111. Zhou HB, Collins ML, Gunther JR, Comninos JS, Katzenellenbogen JA. Bicyclo[2.2.2]octanes: close structural mimics of the nuclear receptor-binding motif of steroid receptor coactivators. Bioorg Med Chem Lett 17(15):4118-22, 2007. e-Pub 2007. PMID: 17560105.
112. Oldenburg AL, Gunther JR, Boppart SA. Imaging magnetically labeled cells with magnetomotive optical coherence tomography. Opt Lett 30(7):747-9, 2005. PMID: 15832926.

Invited Articles

1. Ye JC, Thomas CR, Braunstein S, Hirsch AE, Gunther JR, Golden DW. In Regard to Ahmed et al., Attracting future radiation oncologists: An analysis of the National Resident Matching Program data trends from 2004 to 2015. Int J Radiat Oncol Biol Phys 94(5):1221-2, 2016. e-Pub 2016. PMID: 27026323.
2. Chadha AS, Khoo A, Aliru M, Arora HK, Gunther JR, Krishnan S. Recent Advances in and Prospects for Multi-Modality Therapy in Pancreatic Cancer. Semin Radiat Oncol 26(4):320-337, 2016.
3. Gunther JR, Walker GV. Impact of Pretreatment Combined 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer. Breast Diseases: A Year Book Quarterly 27(1):77-78, 2016.
4. Gunther JR, Krishnan S. The evolving evidence for the efficacy and safety of charged particle therapy for hepatocellular carcinoma—a commentary. Ann Transl Med 3(22):364, 2015.
5. Gunther JR, Liauw S, Choi S, Stepaniak C, Das P, Golden D. Post-Operative Prostate and Seminal Vesicle Fossae Contouring Module: Evaluation of Medical Student Target Delineation Before and After a Teaching Intervention. MedEdPORTAL Publications, 2015.
6. Milgrom SA, Pinnix CC, Gunther JR, Fanale M, Dabaja BS. In response to Drs. Adams and Kwee. Br J Haematol.

Abstracts

1. Toomey S, Carr A, Gunther JR, Fay J, O'Grady A, Weksberg D, Piraino SW, Kay E, O'Neill B, Krishnan S, Furney SJ, Hennessy B. Clonal evolution in locally advanced rectal cancers in response to neoadjuvant chemoradiotherapy. J Clin Oncol 35(15):S3616-3616, 2017.
2. Sato M, Gunther JR, Mahajan A, Jo E, Paulino AC, Adesina AM, Jones JY, Ketonen LM, Su JM, Okcu MF, Khatua S, Dauser RC, Whitehead WE, Weinberg J, Chintagumpala MM. Progression-Free Survival of Children with Localized Ependymoma Treated With Intensity-Modulated Radiation Therapy or Proton-Beam Radiation Therapy. Cancer 123(13):2570-2578, 2017.
3. Gunther JR, Parekh A, Berman AT, Braunstein SE, Hirsch AE, Yechieli R, Fields EC, Jimenez RB, Gillespie EF, Thomas Jr CR, Golden DW. Assessment of Program Director and Resident Needs for a Structured Introductory Radiation Oncology Curriculum and Boot Camp. Int J Radiat Oncol Biol Phys 99(2, Suppl 1):E124-E125, 2017.
4. Zhu F, Gillespie EF, Gunther JR, McKillip RP, Lineberry M, Tekian A, Golden DW. Simulation As More Than a Treatment Planning Tool: A Systematic Review of the Radiation Oncology Simulation-Based Medical Education Literature. Int J Radiat Oncol Biol Phys 99(2, Suppl 1):E131-E132, 2017.
5. Gunther JR, Chadha AS, Yang PY, Munsell MF, Das P, Delclos ME, Foo WC, Kaur H, Clemons M, Mathew GG, Chang GJ, Rodriguez-Bigas MA, Skibber JM, Bhutani M, Raju GS, Eng C, Guha S, Krishnan S. A Phase 2 Randomized Double Blinded Study Evaluating the Efficacy of Curcumin with Pre-Operative Chemoradiation for Rectal Cancer. Int J Radiat Oncol Biol Phys 98(2):E7-E7, 2017.
6. Toomey S, Carr A, Gunther JR, Fay J, O'Grady A, Weksberg D, Piraino SW, Kay E, O'Neill B, Krishnan S, Furney SJ, Hennessy B. Clonal evolution in locally advanced rectal cancers in response to neoadjuvant chemoradiotherapy. J Clin Oncol 35(15), 2017.
7. Akhtari M, Reddy J, Dong W, Milgrom SA, Smith,GL, Pinnix CC, Abou Yehia Z, Gunther JR, Osborne EM, Mawlawi OR, Rohren EM, Chuang HH, Garg N, Fanale M, Dabaja B. Restratifying Early-Stage Hodgkin Lymphoma Patients Using Novel Functional Imaging Parameters. Int J Radiat Oncol Biol Phys 96(2):S40-S40, 2016.
8. Gunther JR, Fanale M, Reddy J, Akhtari M, Smith GL, Pinnix CC, Milgrom SA, Abou Yehia Z, Osborne EM, Mawlawi OR, Allen PK, Dabaja B. Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy with Radiation. Int J Radiat Oncol Biol Phys 96(2, Suppl 1):S21-S22, 2016.
9. Milgrom SA, Smith GL, Pinnix CC, Dong W, Akhtari M, Mawlawi OR, Rohren EM, Garg N, Chuang HH, Reddy J, Gunther JR, Osborne EM, Abou Yehia Z, Oki Y, Fanale M, Dabaja, B. Adjuvant Therapy Improves Outcomes in Completely Resected, Limited-Stage Follicular Lymphoma. Int J Radiat Oncol Biol Phys 96(2, Suppl 1):S167-S167, 2016.
10. Milgrom SA, Dong W, Akhtari M, Smith GL, Pinnix CC, Mawlawi OR, Rohren EM, Garg N, Chuang HH, Abou Yehia Z, Reddy J, Gunther JR, Osborne EM, Oki Y, Fanale M, Dabaja, B. Postchemotherapy Positron Emission Tomography/Computed Tomography Scans in Early-Stage Hodgkin Lymphoma: Moving Beyond the Deauville 5-Point Scale. Int J Radiat Oncol Biol Phys 96(2, Suppl 1):S40-S41, 2016.
11. Pinnix CC, Abou Yehia Z, Qiao W, Milgrom SA, Smith GL, Akhtari M, Reddy J, Gunther JR, Osborne EM, Mawlawi OR, Medeiros LJ, Garg N, Chuang HH, Neelapu S, Westin JR, Dabaja, B. Utilization of Positron Emission Tomography/Computed Tomography Parameters to Identify Patients at Risk for Progression After Treatment with Dose-Adjusted R-EPOCH for Primary Mediastinal B-Cell Lymphoma (PMBCL). Int J Radiat Oncol Biol Phys 96(2, Suppl 1):S20-S21, 2016.
12. Reddy J , Gunther JR, Dabaja B, Akhtari M, Martin GV, Allen PK, Aktinson BJ, Smith GL, Pinnix CC, Milgrom SA, Abou Yehia Z, Osborne EM, Fanale M. Pretreatment Neutrophil/Lymphocyte Ratio Predicts Relapse in Stage I and II Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys 96(2, Suppl 1):S22-S23, 2016.
13. Gillespie EF, Panjwani N, Golden DW, Gunther JR, Chapman TR, Brower JV, Kosztyla R, Bykowski JM, Sanghvi P, Murphy JD. Educational Impact of a Novel Web-Based Interactive Contouring Atlas Among Radiation Oncology Residents in a Multi-Institutional Randomized Trial. Int J Radiat Oncol Biol Phys 96(2, Suppl 1):E416-E417, 2016.
14. Kauffmann G, Gunther JR, Braunstein SE, Hara W, Spektor A, Brower JV, Stahl JM, Rao YJ, Vargo J, Ye, JC, Fields EC, Thomas CR, Du KL, Kruser TJ, Jimenez RB, Hirsch AE, Currey AD, Yechieli R, Mohindra P, Golden DW. Updated Analysis of a Multi-Institutional Radiation Oncology Clerkship Curriculum: A Report From the Radiation Oncology Education Collaborative Study Group. Int J Radiat Oncol Biol Phys 96(2, Suppl 1):E412, 2016.
15. Martin GV, Gunther JR, Rao A, Kaur H, Narang S, Chadha AS, Krishnan S. Magnetic Resonance Imaging But Not Computed Tomography Radiomic Features Predict Rectal Cancer Response to Neoadjuvant Chemoradiation. Int J Radiat Oncol Biol Phys 96(2, Suppl 1):E620, 2016.
16. Panjwani N, Gillespie EF, Golden DW, Gunther JR, Chapman TR, Brower JV, Bykowski JM, Sanghvi P, Murphy JD. Usability of a Novel Interactive Web-Based Contouring Atlas. Int J Radiat Oncol Biol Phys 96(2, Suppl 1):E415-E416, 2016.
17. Pinnix CC, Abou Yehia Z, Smith GL, Milgrom SA, Ho JC, Reddy J, Gunther JR, Akhtari M, Osborne EM, Medeiros LJ, Fanale M, Dabaja B. More Chemotherapy Does Not Obviate the Need for Radiation Therapy (RT): Treatment for Early-Stage Favorable Hodgkin Lymphoma According to the HD10 Trial Compared with Chemotherapy Alone. Int J Radiat Oncol Biol Phys 96(2, Suppl 1):E489-E490, 2016.
18. Chadha AS, Gunther JR, Minsky BD, Taniguchi CM, Mahmood U, Delclos ME, Suh Y, Sawakuchi GO, Park PC, Beddar S, Gupta S, Kaur H, Javle MM, Kaseb AO, Koay EJ , Das P, Crane, CH, Krishnan S. Proton Therapy Outcomes for Localized, Unresectable Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys 96(2, Suppl 1):E181-E182, 2016.
19. Gunther JR, Yang J, Bhosale P, Williamson RT, Klopp AH, Jhingran A, Eifel PJ. Anatomic Distribution of Inguinal Lymph Nodes in Patients with Vulvar Carcinoma. Int J Radiat Oncol Biol Phys 96(2, Suppl 1):E288, 2016.
20. Stecklein SR, Frumovitz M, Klopp AH, Gunther JR, Eifel PJ. Definitive Radiotherapeutic Management of Inguinal Lymph Node Metastasis in Vulvar Cancer. Int J Gynecol Ca 26(Supp 3):1160-1161, 2016.
21. Gunther JR, Chadha AS, Arora HK, Krishnan S. Neutrophil-Lymphocyte Ratio During Chemoradiation Predicts Pathologic Tumor Response for Rectal Cancer Patients. GASTROENTEROLOGY 150(4, Suppl 1):S614-S614, 2016.
22. Abou Yehia Z, Tang C, Milgrom SA, Fanale M, Smith GL, Pinnix CC, Reddy J, Akhtari M, Gunther JR, Osborne EM, Ahmed S, Dabaja B. Bone Involvement: A Poor Prognostic Factor in Stage IV Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys 93(3):E456-E456, 2015.
23. Akhtari M, Reddy J, Pinnix CC, Allen PK, Osborne EM, Gunther JR, Milgrom SA, Smith GL, Wogan CF, Fowler N, Rodriguez MA, Dabaja B. Excellent Outcomes in Primary Cutaneous B-cell Lymphoma After Very Low Dose Radiation. Int J Radiat Oncol Biol Phys 93(3, Suppl S):E448-E448, 2015.
24. Braunstein SE, Gunther JR, Spektor A, Falit B, Mirabeau-Beale KL, Young K, Brower JV, Mancini BR, Ye JC, Rajagopalan MS, Du KL, Rao YJ, Hara W, Currey AD, Jimenez RB, Golden DW. Role of the Resident as a Teacher (RAT) in the Medical Student (MS) Clerkship: A Report From the Radiation Oncology Education Collaborative Study Group. Int J Radiat Oncol Biol Phys 93(3, Suppl S):E379-E379, 2015.
25. Golden DW, Spektor A, Gunther JR, Thaker NG, Braunstein SE, Young K, Bornstein S, Hung AY, Brower JV, Mohindra P, Mancini BR, Ye JC, Rajagopalan MS, Du KL, Rao YJ, Gibbs IC, Hara W, Kharofa JR, Currey AD, Jimenez RB. Evaluation of a Multi-institutional Radiation Oncology Clerkship Curriculum: A Report From the Radiation Oncology Education Collaborative Study Group. Int J Radiat Oncol Biol Phys 93(3, Suppl S):E376-E376, 2015.
26. Gunther JR, Liauw S, Choi S, Mohamed ASR, Thaker NG, Fuller CD, Stepaniak CJ, Das P, Golden DW. Evaluation of Clinical Target Volume Delineation Before and After a Teaching Intervention: Creation of a Postoperative Prostate and Seminal Vesicle Fossae Contouring Module. Int J Radiat Oncol Biol Phys 93(3):E373, 2015.
27. Reddy J, Akhtari M, Smith GL, Pinnix CC, Osborne EM, Gunther JR, Allen PK, Fanale M, Rodriguez MA, Fowler N, Milgrom SA, Wogan CF, Dabaja B. Outcomes After Chemotherapy Followed by Radiation for Stage IIB Hodgkin Lymphoma with Bulky Disease. Int J Radiat Oncol Biol Phys 93(3):S82, 2015.
28. Gunther JR, Sato M, Chintagumpala M, Jo E, Paulino A, Adesina A, Ketonen L, Su J, Okcu E, Khatua S, Dauser R, Whitehead W, Weinberg J, Mahajan, A. Comparison of Imaging Changes in Pediatric Patients Treated with Proton Beam Radiation Therapy Versus Intensity Modulated Radiation Therapy for Intra-cranial Ependymoma. Int J Radiat Oncol Biol Phys 90(Suppl 1):S115, 2014.
29. Thaker NG, Komaki R, Golden DW, Boehling NS, Gunther JR, Hillebrandt E, Mahajan A, Cox JD, Frank SJ, Woodward WA, Das P. Improving the Quality of Radiation Oncology Education Through an Innovative Medical Student Treatment Planning Curriculum. Int J Radiat Oncol Biol Phys 90(Suppl 1):S601, 2014.
30. Parent AA, Gunther JR, Katzenellenbogen JA. Tetra-aryl cyclobutanes as direct inhibitors of the nuclear receptor/coactivator interaction. Abstracts of Papers of the American Chemical Society 240, 2010.
31. Sun AM, Moore T, Gunther JR, Kim MS, Rhoden E, Du YH, Fu HA, Snyder JP, Katzenellenbogen JA. Small molecule inhibitors of estrogen receptor a/coactivator binding: Synthesis and in vitro and cell-based biological evaluation. Abstracts of Papers of the American Chemical Society 239, 2010.
32. Moore TW, Gunther JR, Katzenellenbogen JA. Estrogen receptor (ER) ligands that recruit FK506 binding proteins: A novel mechanism of ER antagonism?. Abstracts of Papers of the American Chemical Society 233:647, 2010.
33. Parent AA, Gunther JR, Amin JP, Katzenellenbogen JA. Pyrimidine core small molecule inhibitors of estrogen and androgen receptor-coactivator binding. Abstracts of Papers from the American Chemical Society 233:658, 2010.

Book Chapters

1. Gunther JR, Dabaja BS. Proton Therapy for Hematologic Malignancies. In: Proton Therapy. 1st. Elsevier: Philadelphia, PA, 2020.
2. Sheu T, Gunther J, Dabaja B. Hodgkin Lymphoma. In: Pocket Radiation Oncology. Wolters Kluwer: China, 12-1, 2019.
3. Moore T, Gunther J, Katzenellenbogen J. Estrogen Receptor Alpha/Co-activator Interaction Assay: TR-FRET. In: Protein-Protein Interactions: Methods and Applications. 2nd Edition. Humana Press: New York, NY, 2015.

Letters to the Editor

1. Ye JC, Thomas Jr. CR, Braunstein S, Hirsch AE, Gunther JR, Golden DW. Attracting Future Radiation Oncologists: An Analysis of the National Resident Matching Program Data Trends from 2004 to 2015 94: 1221–1222, 2016.